作者
Rahul K Suryawanshi, Irene P Chen, Tongcui Ma, Abdullah M Syed, Noah Brazer, Prachi Saldhi, Camille R Simoneau, Alison Ciling, Mir M Khalid, Bharath Sreekumar, Pei-Yi Chen, G Renuka Kumar, Mauricio Montano, Ronne Gascon, Chia-Lin Tsou, Miguel A Garcia-Knight, Alicia Sotomayor-Gonzalez, Venice Servellita, Amelia Gliwa, Jenny Nguyen, Ines Silva, Bilal Milbes, Noah Kojima, Victoria Hess, Maria Shacreaw, Lauren Lopez, Matthew Brobeck, Fred Turner, Frank W Soveg, Ashley F George, Xiaohui Fang, Mazharul Maishan, Michael Matthay, Mary Kate Morris, Debra Wadford, Carl Hanson, Warner C Greene, Raul Andino, Lee Spraggon, Nadia R Roan, Charles Y Chiu, Jennifer A Doudna, Melanie Ott
发表日期
2022/7/14
期刊
Nature
卷号
607
期号
7918
页码范围
351-355
出版商
Nature Publishing Group UK
简介
SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although individuals infected with Delta are at risk of developing severe lung disease, infection with Omicron often causes milder symptoms, especially in vaccinated individuals,. The question arises of whether widespread Omicron infections could lead to future cross-variant protection, accelerating the end of the pandemic. Here we show that without vaccination, infection with Omicron induces a limited humoral immune response in mice and humans. Sera from mice overexpressing the human ACE2 receptor and infected with Omicron neutralize only Omicron, but not other variants of concern, whereas broader cross-variant neutralization was observed after WA1 and Delta infections. Unlike WA1 and Delta, Omicron replicates to low levels in the lungs and brains of infected animals, leading to mild disease with reduced expression of pro …
引用总数
学术搜索中的文章